News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rumor: AstraZeneca PLC (AZN) Actively Pursued Forest Laboratories, Inc. (FRX)



2/26/2014 7:33:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

British drug maker AstraZeneca AZN.LN -0.43% PLC recently made an abortive acquisition approach to Forest Laboratories Inc. FRX +1.16% before the specialty-drug company agreed last week to be bought by Actavis PLC for $25 billion, according to people familiar with the matter. Late last year, AstraZeneca approached Forest about a deal for around $70 a share, according to some of the people. The cash-and-stock deal that Actavis ACT +2.16% sealed valued Forest at $89.48 a share.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES